Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Laboratory Corporation of America Holdings
27.3% sales growth and 10.9% return on equity
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide.
Laboratory Corporation of America Holdings sales growth this year is anticipated to be 15.7% and 4.2% for next year.
Year-on-year quarterly revenue growth grew by 33%, now sitting on 12.44B for the twelve trailing months.
Laboratory Corporation of America Holdings's sales growth for the next quarter is 27.3%. The company's growth estimates for the current quarter and the next is 146.9% and 133.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.9%.
Laboratory Corporation of America Holdings's Stock Top and Bottom Yearly Value
Laboratory Corporation of America Holdings's stock is valued at $207.59 at 07:57 EST, under its 52-week high of $218.77 and way higher than its 52-week low of $98.02.
Laboratory Corporation of America Holdings's Moving Average
Laboratory Corporation of America Holdings's worth is higher than its 50-day moving average of $202.71 and way above its 200-day moving average of $187.60.2. Genmab A/S
47.1% sales growth and 36.46% return on equity
Genmab A/S, a biotechnology company, develops antibody therapeutics for the treatment of cancer primarily in Denmark.
Genmab A/S sales growth this year is anticipated to be 99.4% and a negative 20.4% for next year.
Year-on-year quarterly revenue growth grew by 65.8%, now sitting on N/A for the twelve trailing months.
Genmab A/S's sales growth for the next quarter is 47.1%. The company's growth estimates for the ongoing quarter and the next is a negative 66.3% and 30%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 36.46%.
Genmab A/S's Stock Top and Bottom Yearly Value
Genmab A/S's stock is valued at $38.45 at 07:57 EST, below its 52-week high of $39.81 and way higher than its 52-week low of $16.24.
Genmab A/S's Moving Average
Genmab A/S's value is above its 50-day moving average of $36.29 and above its 200-day moving average of $35.16.3. Flushing Financial Corporation
29.8% sales growth and 7.64% return on equity
Flushing Financial Corporation operates as the bank holding company for Flushing Bank that provides banking products and services primarily to consumers, businesses, and governmental units.
Flushing Financial Corporation sales growth this year is expected to be 19.8% and 13.4% for next year.
Year-on-year quarterly revenue growth grew by 24.2%, now sitting on 178.96M for the twelve trailing months.
Flushing Financial Corporation's sales growth for the next quarter is 29.8%. The company's growth estimates for the current quarter and the next is 5% and 121.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.64%.
Flushing Financial Corporation's Stock Top and Bottom Yearly Value
Flushing Financial Corporation's stock is valued at $16.09 at 07:57 EST, way under its 52-week high of $22.10 and way higher than its 52-week low of $8.86.
Flushing Financial Corporation's Moving Average
Flushing Financial Corporation's worth is way higher than its 50-day moving average of $13.96 and way above its 200-day moving average of $12.07.4. Capital Bancorp, Inc.
47.1% sales growth and 15.3% return on equity
Capital Bancorp, Inc. operates as the bank holding company for Capital Bank, N.
Capital Bancorp, Inc. sales growth this year is expected to be 50.4% and 3.5% for next year.
Year-on-year quarterly revenue growth grew by 63.1%, now sitting on 115.18M for the twelve trailing months.
Capital Bancorp, Inc.'s sales growth for the next quarter is 47.1%. The company's growth estimates for the ongoing quarter and the next is 50% and 95.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.3%.
Capital Bancorp, Inc.'s Stock Top and Bottom Yearly Value
Capital Bancorp, Inc.'s stock is valued at $12.78 at 07:57 EST, way below its 52-week high of $14.97 and way above its 52-week low of $6.98.